Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson's disease

Human Brain Mapping

Volumn 34, Issue 7, 2013, Pages 1591-1604

  Ko, Ji Hyun ^a   Antonelli, Francesca ^a   Monchi, Oury ^b   Ray, Nicola ^a   Rusjan, Pablo ^a   Houle, Sylvain ^a   Lang, Anthony E ^a   Christopher, Leigh ^a   Strafella, Antonio P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE DE RECHERCHE   (Canada)

Author keywords

Cognition; FLB 457; Mesocortical dopamine; Positron emission tomography; Set shifting

Indexed keywords

CARBON 11; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR; ISOREMOXIPRIDE; LEVODOPA;

ADULT; AGED; ANTERIOR CINGULATE; ARTICLE; BINDING AFFINITY; BRAIN REGION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DOPAMINE RELEASE; EXECUTIVE FUNCTION; FEMALE; HUMAN; IMAGE ANALYSIS; ISOTOPE LABELING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; PARKINSON DISEASE; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECEPTOR BINDING; TASK PERFORMANCE; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; AGED, 80 AND OVER; BRAIN MAPPING; CARBON ISOTOPES; COGNITION DISORDERS; DOPAMINE ANTAGONISTS; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; PYRROLIDINES; RECEPTORS, DOPAMINE; SALICYLAMIDES; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC;

EID: 84877009327     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22006     Document Type: Article

References (98)

1. Aalto S, Bruck A, Laine M, Nagren K, Rinne JO (2005): Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: A positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457. J Neurosci 25: 2471-2477.
2. Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P (2001): Risk of dementia in Parkinson's disease: A community-based, prospective study. Neurology 56: 730-736.
3. Aston JA, Gunn RN, Worsley KJ, Ma Y, Evans AC, Dagher A (2000): A statistical method for the analysis of positron emission tomography neuroreceptor ligand data. Neuroimage 12: 245-256.
4. Botvinick MM, Braver TS, Barch DM, Carter CS, Cohen JD (2001): Conflict monitoring and cognitive control. Psychol Rev 108: 624-652.
5. Botvinick MM, Cohen JD, Carter CS (2004): Conflict monitoring and anterior cingulate cortex: An update. Trends Cogn Sci 8: 539-546.
6. Bruck A, Aalto S, Nurmi E, Bergman J, Rinne JO (2005): Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease. Neurobiol Aging 26: 891-898.
7. Buchsbaum BR, Greer S, Chang WL, Berman KF (2005): Meta-analysis of neuroimaging studies of the Wisconsin card-sorting task and component processes. Hum Brain Mapp 25: 35-45.
8. Bush G, Luu P, Posner MI (2000): Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 4: 215-222.
9. Calne DB, Zigmond MJ (1991): Compensatory mechanisms in degenerative neurologic diseases. Insights from parkinsonism. Arch Neurol 48: 361-363.
10. Carbon M, Ma Y, Barnes A, Dhawan V, Chaly T, Ghilardi MF, Eidelberg D (2004): Caudate nucleus: Influence of dopaminergic input on sequence learning and brain activation in Parkinsonism. Neuroimage 21: 1497-1507.
11. Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, Evidente VG, Shill HA, Adler CH (2007): Defining mild cognitive impairment in Parkinson's disease. Mov Disord 22: 1272-1277.
12. Collins DL, Neelin P, Peters TM, Evans AC (1994): Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18: 192-205.
13. Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM (2002): Dopaminergic modulation of high-level cognition in Parkinson's disease: The role of the prefrontal cortex revealed by PET. Brain 125(Part 3): 584-594.
14. Defer GL, Widner H, Marie RM, Remy P, Levivier M (1999): Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 14: 572-584.
15. Defrise M, Kinahan P, Townsend D, Michel C, Sibomana M, Newport D (1997): Exact and approximate rebinning algorithms for 3-D PET data. IEEE Trans Med Imaging 16: 145-158.
16. Dubois B, Pillon B (1997): Cognitive deficits in Parkinson's disease. J Neurol 244: 2-8.
17. Fellows LK (2007): The role of orbitofrontal cortex in decision making: A component process account. Ann NY Acad Sci 1121: 421-430.
18. Frankle WG, Mason NS, Rabiner EA, Ridler K, May MA, Asmonga D, Chen CM, Kendro S, Cooper TB, Mathis CA, and others (2010): No effect of dopamine depletion on the binding of the high-affinity D(2/3) radiotracer [11C]FLB 457 in the human cortex. Synapse 64: 879-885.
19. Friston KJ (1997): Testing for anatomically specified regional effects. Hum Brain Mapp 5: 133-136.
20. Fujita M, Verhoeff NP, Varrone A, Zoghbi SS, Baldwin RM, Jatlow PA, Anderson GM, Seibyl JP, Innis RB (2000): Imaging extrastriatal dopamine D(2) receptor occupancy by endogenous dopamine in healthy humans. Eur J Pharmacol 387: 179-188.
21. Grahn JA, Parkinson JA, Owen AM (2008): The cognitive functions of the caudate nucleus. Prog Neurobiol 86: 141-155.
22. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ (1997): Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6: 279-287.
23. Hagelberg N, Aalto S, Kajander J, Oikonen V, Hinkka S, Nagren K, Hietala J, Scheinin H (2004): Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects. Pain 109(1-2): 86-93.
24. Hampshire A, Owen AM (2006): Fractionating attentional control using event-related fMRI. Cereb Cortex 16: 1679-1689.
25. Holroyd S, Currie L, Wooten GF (2001): Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry 70: 734-738.
26. Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D (2009): Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 73: 1738-1745.
27. Hume SP, Opacka-Juffry J, Myers R, Ahier RG, Ashworth S, Brooks DJ, Lammertsma AA (1995): Effect of L-dopa and 6-hydroxydopamine lesioning on [11C]raclopride binding in rat striatum, quantified using PET. Synapse 21: 45-53.
28. Inoue M, Suhara T, Sudo Y, Okubo Y, Yasuno F, Kishimoto T, Yoshikawa K, Tanada S (2001): Age-related reduction of extrastriatal dopamine D2 receptor measured by PET. Life Sci 69: 1079-1084.
29. Ismail Z, Rajji TK, Shulman KI (2010): Brief cognitive screening instruments: An update. Int J Geriatr Psychiatry 25: 111-120.
30. Jaffard M, Benraiss A, Longcamp M, Velay JL, Boulinguez P (2007): Cueing method biases in visual detection studies. Brain Res 1179: 106-118.
31. Jaffard M, Longcamp M, Velay JL, Anton JL, Roth M, Nazarian B, Boulinguez P (2008): Proactive inhibitory control of movement assessed by event-related fMRI. Neuroimage 42: 1196-1206.
32. Ji Y, Yang F, Papaleo F, Wang HX, Gao WJ, Weinberger DR, Lu B (2009): Role of dysbindin in dopamine receptor trafficking and cortical GABA function. Proc Natl Acad Sci USA 106: 19593-19598.
33. Kaasinen V, Aalto S, K NA, Hietala J, Sonninen P, Rinne JO (2003): Extrastriatal dopamine D(2) receptors in Parkinson's disease: A longitudinal study. J Neural Transm 110: 591-601.
34. Kaasinen V, Kemppainen N, Nagren K, Helenius H, Kurki T, Rinne JO (2002): Age-related loss of extrastriatal dopamine D(2) -like receptors in women. J Neurochem 81: 1005-1010.
35. Kaasinen V, Nagren K, Hietala J, Oikonen V, Vilkman H, Farde L, Halldin C, Rinne JO (2000a): Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease. Neurology 54: 1482-1487.
36. Kaasinen V, Nurmi E, Bruck A, Eskola O, Bergman J, Solin O, Rinne JO (2001): Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: Sex differences in the prefrontal cortex. Brain 124(Part 6): 1125-1130.
37. Kaasinen V, Vilkman H, Hietala J, Nagren K, Helenius H, Olsson H, Farde L, Rinne J (2000b): Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain. Neurobiol Aging 21: 683-688.
38. Kehagia AA, Cools R, Barker RA, Robbins TW (2009): Switching between abstract rules reflects disease severity but not dopaminergic status in Parkinson's disease. Neuropsychologia 47: 1117-1127.
39. Kehagia AA, Murray GK, Robbins TW (2010): Learning and cognitive flexibility: Frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol 20: 199-204.
40. Klein JC, Eggers C, Kalbe E, Weisenbach S, Hohmann C, Vollmar S, Baudrexel S, Diederich NJ, Heiss WD, Hilker R (2010): Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology 74: 885-892.
41. Ko JH, Monchi O, Ptito A, Bloomfield P, Houle S, Strafella AP (2008a): Theta burst stimulation-induced inhibition of dorsolateral prefrontal cortex reveals hemispheric asymmetry in striatal dopamine release during a set-shifting task: A TMS-[(11)C]raclopride PET study. Eur J Neurosci 28: 2147-2155.
42. Ko JH, Monchi O, Ptito A, Petrides M, Strafella AP (2008b): Repetitive transcranial magnetic stimulation of dorsolateral prefrontal cortex affects performance of the wisconsin card sorting task during provision of feedback. Int J Biomed Imaging 2008: 143238.
43. Ko JH, Ptito A, Monchi O, Cho SS, Van Eimeren T, Pellecchia G, Ballanger B, Rusjan P, Houle S, Strafella AP (2009): Increased dopamine release in the right anterior cingulate cortex during the performance of a sorting task: A [11C]FLB 457 PET study. Neuroimage 46: 516-521.
44. Konishi S, Hayashi T, Uchida I, Kikyo H, Takahashi E, Miyashita Y (2002): Hemispheric asymmetry in human lateral prefrontal cortex during cognitive set shifting. Proc Natl Acad Sci USA 99: 7803-7808.
45. Koski L, Paus T (2000): Functional connectivity of the anterior cingulate cortex within the human frontal lobe: A brain-mapping meta-analysis. Exp Brain Res 133: 55-65.
46. Kringelbach ML, Rolls ET (2004): The functional neuroanatomy of the human orbitofrontal cortex: Evidence from neuroimaging and neuropsychology. Prog Neurobiol 72: 341-372.
47. Lammertsma AA, Hume SP (1996): Simplified reference tissue model for PET receptor studies. Neuroimage 4(3 Part 1): 153-158.
48. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, Watts R (1992): Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 7: 2-13.
49. Laruelle M (2000): Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review. J Cereb Blood Flow Metab 20: 423-451.
50. Leh SE, Petrides M, Strafella AP (2010): The neural circuitry of executive functions in healthy subjects and Parkinson's disease. Neuropsychopharmacology 35: 70-85.
51. Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM (2003): Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 23: 6351-6356.
52. Lie CH, Specht K, Marshall JC, Fink GR (2006): Using fMRI to decompose the neural processes underlying the Wisconsin Card Sorting Test. Neuroimage 30: 1038-1049.
53. Lumme V, Aalto S, Ilonen T, Nagren K, Hietala J (2007): Dopamine D2/D3 receptor binding in the anterior cingulate cortex and executive functioning. Psychiatry Res 156: 69-74.
54. Luu P, Flaisch T, Tucker DM (2000): Medial frontal cortex in action monitoring. J Neurosci 20: 464-469.
55. MacDonald AW III, Cohen JD, Stenger VA, Carter CS (2000): Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control. Science 288: 1835-1838.
56. MacDonald SW, Cervenka S, Farde L, Nyberg L, Backman L (2009): Extrastriatal dopamine D2 receptor binding modulates intraindividual variability in episodic recognition and executive functioning. Neuropsychologia 47: 2299-2304.
57. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003): An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19: 1233-1239.
58. Mattay VS, Tessitore A, Callicott JH, Bertolino A, Goldberg TE, Chase TN, Hyde TM, Weinberger DR (2002): Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 51: 156-164.
59. Mayeux R, Denaro J, Hemenegildo N, Marder K, Tang MX, Cote LJ, Stern Y (1992): A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol 49: 492-497.
60. Milner B (1972): Disorders of learning and memory after temporal lobe lesions in man. Clin Neurosurg 19: 421-446.
61. Monchi O, Ko JH, Strafella AP (2006): Striatal dopamine release during performance of executive functions: A [(11)C] raclopride PET study. Neuroimage 33: 907-912.
62. Monchi O, Petrides M, Doyon J, Postuma RB, Worsley K, Dagher A (2004): Neural bases of set-shifting deficits in Parkinson's disease. J Neurosci 24: 702-710.
63. Monchi O, Petrides M, Mejia-Constain B, Strafella AP (2007): Cortical activity in Parkinson's disease during executive processing depends on striatal involvement. Brain 130(Part 1): 233-244.
64. Monchi O, Petrides M, Petre V, Worsley K, Dagher A (2001): Wisconsin Card Sorting revisited: Distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. J Neurosci 21: 7733-7741.
65. Murata M, Kanazawa I (1993): Repeated L-dopa administration reduces the ability of dopamine storage and abolishes the supersensitivity of dopamine receptors in the striatum of intact rat. Neurosci Res 16: 15-23.
66. Muslimovic D, Post B, Speelman JD, Schmand B (2005): Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65: 1239-1245.
67. Narendran R, Frankle WG, Mason NS, Rabiner EA, Gunn RN, Searle GE, Vora S, Litschge M, Kendro S, Cooper TB, et al. (2009): Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride. Synapse 63: 447-461.
68. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005): The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53: 695-699.
69. Oldfield RC (1971): The assessment and analysis of handedness: The Edinburgh inventory. Neuropsychologia 9: 97-113.
70. Olsson H, Halldin C, Farde L (2004): Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET. Neuroimage 22: 794-803.
71. Opacka-Juffry J, Ashworth S, Ahier RG, Hume SP (1998): Modulatory effects of L-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET. J Neural Transm 105(4-5): 349-364.
72. Owen AM (2000): The role of the lateral frontal cortex in mnemonic processing: The contribution of functional neuroimaging. Exp Brain Res 133: 33-43.
73. Owen AM (2004): Cognitive dysfunction in Parkinson's disease: The role of frontostriatal circuitry. Neuroscientist 10: 525-537.
74. Owen AM, Doyon J, Dagher A, Sadikot A, Evans AC (1998): Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions. Brain 121 (Part 5): 949-965.
75. Petrides M (2005): Lateral prefrontal cortex: Architectonic and functional organization. Philos Trans R Soc Lond B Biol Sci 360: 781-795.
76. Piggott MA, Ballard CG, Rowan E, Holmes C, McKeith IG, Jaros E, Perry RH, Perry EK (2007): Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline. Synapse 61: 903-911.
77. Rakshi JS, Uema T, Ito K, Bailey DL, Morrish PK, Ashburner J, Dagher A, Jenkins IH, Friston KJ, Brooks DJ (1999): Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study. Brain 122 (Part 9): 1637-1650.
78. Riccardi P, Baldwin R, Salomon R, Anderson S, Ansari MS, Li R, Dawant B, Bauernfeind A, Schmidt D, Kessler R (2008): Estimation of baseline dopamine D2 receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [18F] fallypride. Biol Psychiatry 63: 241-244.
79. Rinne JO, Portin R, Ruottinen H, Nurmi E, Bergman J, Haaparanta M, Solin O (2000): Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. Arch Neurol 57: 470-475.
80. Robbins S, Evans AC, Collins DL, Whitesides S (2004): Tuning and comparing spatial normalization methods. Med Image Anal 8: 311-323.
81. Rowe JB, Hughes L, Ghosh BC, Eckstein D, Williams-Gray CH, Fallon S, Barker RA, Owen AM (2008): Parkinson's disease and dopaminergic therapy-Differential effects on movement, reward and cognition. Brain 131(Part 8): 2094-2105.
82. Rowe JB, Hughes LE, Barker RA, Owen AM (2010): Dynamic causal modelling of effective connectivity from fMRI: Are results reproducible and sensitive to Parkinson's disease and its treatment? Neuroimage 52: 1015-1026.
83. Scatton B, Rouquier L, Javoy-Agid F, Agid Y (1982): Dopamine deficiency in the cerebral cortex in Parkinson disease. Neurology 32: 1039-1040.
84. Seamans JK, Yang CR (2004): The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74: 1-58.
85. Skinbjerg M, Liow JS, Seneca N, Hong J, Lu S, Thorsell A, Heilig M, Pike VW, Halldin C, Sibley DR, et al. (2010): D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: A PET study in a receptor internalization-deficient mouse model. Neuroimage 50: 1402-1407.
86. Stuss DT, Alexander MP (2007): Is there a dysexecutive syndrome? Philos Trans R Soc Lond B Biol Sci 362: 901-915.
87. Sudo Y, Suhara T, Inoue M, Ito H, Suzuki K, Saijo T, Halldin C, Farde L (2001): Reproducibility of [11 C]FLB 457 binding in extrastriatal regions. Nucl Med Commun 22: 1215-1221.
88. Svenningsson P, Gunne L, Andren PE (2000): L-DOPA produces strong induction of c-fos messenger RNA in dopamine-denervated cortical and striatal areas of the common marmoset. Neuroscience 99: 457-468.
89. Takahashi H, Kato M, Hayashi M, Okubo Y, Takano A, Ito H, Suhara T (2007): Memory and frontal lobe functions; possible relations with dopamine D2 receptors in the hippocampus. Neuroimage 34: 1643-1649.
90. Takahashi H, Kato M, Takano H, Arakawa R, Okumura M, Otsuka T, Kodaka F, Hayashi M, Okubo Y, Ito H, et al. (2008): Differential contributions of prefrontal and hippocampal dopamine D(1) and D(2) receptors in human cognitive functions. J Neurosci 28: 12032-12038.
91. Talairach J, Tournoux P (1988): Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging. New York: Thieme Medical Publishers. 122 p.
92. Tedroff J, Pedersen M, Aquilonius SM, Hartvig P, Jacobsson G, Langstrom B (1996): Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET. Neurology 46: 1430-1436.
93. Thobois S, Vingerhoets F, Fraix V, Xie-Brustolin J, Mollion H, Costes N, Mertens P, Benabid AL, Pollak P, Broussolle E (2004): Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: A positron emission tomographic study. Arch Neurol 61: 1705-1709.
94. Walker SC, Robbins TW, Roberts AC (2009): Differential contributions of dopamine and serotonin to orbitofrontal cortex function in the marmoset. Cereb Cortex 19: 889-898.
95. Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA (2007a): Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 130(Part 7): 1787-1798.
96. Williams-Gray CH, Hampshire A, Robbins TW, Owen AM, Barker RA (2007b): Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease. J Neurosci 27: 4832-4838.
97. Woods RP, Mazziotta JC, Cherry SR (1993): MRI-PET registration with automated algorithm. J Comput Assist Tomogr 17: 536-546.
98. Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC (1996): A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 4: 58-73.